A Multicenter Randomized Phase II Study of Erlotinib, Cisplatin and Radiotherapy Versus Cisplatin and Radiotherapy in Patients With Stage III and IV Squamous Cell Carcinoma of the Head and Neck.
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Erlotinib (Primary) ; Cisplatin
- Indications Head and neck cancer; Hypopharyngeal cancer; Laryngeal cancer; Nasopharyngeal cancer; Oropharyngeal cancer
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 07 Jun 2016 Results of an exploratory analysis assessing racial disparity in oncologic and patient-reported quality of life presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 17 Jul 2012 Planned end date changed from 1 Jan 2013 to 1 Mar 2012 as reported by ClinicalTrials.gov.
- 17 Jul 2012 Planned end date changed from 1 Jan 2013 to 1 Mar 2012 as reported by ClinicalTrials.gov.